Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S. G. Nadler
An Anti-Cd154 Domain Antibody Prolongs Graft Survival and Induces Foxp3+iTreg in the Absence and Presence of CTLA-4 Ig
American Journal of Transplantation
Transplantation
Allergy
Immunology
Pharmacology
Related publications
Ipilimumab: An Anti-Ctla-4 Antibody for Metastatic Melanoma
Clinical Cancer Research
Cancer Research
Oncology
Dose-Dependent Effect of Anti-Ctla-4 on Survival in Sepsis
Shock
Critical Care
Emergency Medicine
Intensive Care Medicine
The CTLA-4 X OX40 Bispecific Antibody ATOR-1015 Induces Anti-Tumor Effects Through Tumor-Directed Immune Activation
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Interleukin-13 but Not Interleukin-4 Prolongs Eosinophil Survival and Induces Eosinophil Chemotaxis.
Internal Medicine
Internal Medicine
Medicine
Anti–CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers—Response
Clinical Cancer Research
Cancer Research
Oncology
Conformational Preference of Serogroup B Salmonella O Polysaccharide in Presence and Absence of the Monoclonal Antibody Se155–4
Journal of Physical Chemistry B
Surfaces
Theoretical Chemistry
Materials Chemistry
Films
Medicine
Coatings
Physical
Allogeneic Hematopoietic Chimerism in Mice Treated With Sublethal Myeloablation and Anti-Cd154 Antibody: Absence of Graft-Versus-Host Disease, Induction of Skin Allograft Tolerance, and Prevention of Recurrent Autoimmunity in Islet-Allografted NOD/Lt Mice
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Improved Survival With T Cell Clonotype Stability After Anti-Ctla-4 Treatment in Cancer Patients
Science Translational Medicine
Medicine
Comment on ‘Efficacy and Toxicity of Treatment With the Anti-Ctla-4 Antibody Ipilimumab in Patients With Metastatic Melanoma After Prior Anti-Pd-1 Therapy’
British Journal of Cancer
Cancer Research
Oncology
